UI Hospitals and Clinics
Randomized, Phase II Study of MK-3475 versus Chemotherapy in Patients with Advanced Melanoma
Participants in this research sub-study must initially take part in the main research study "Randomized, Phase II Study of MK-3475 versus Chemotherapy in Patients with Advanced Melanoma." The purpose of the substudy is to find out more about what causes disease and the differences in the way people respond to drug therapies. The study consists of providing blood samples, additional biological samples such as left over tumor biopsy or archival tumor tissue samples collected during the main study.
Melanie Frees, 319-356-1228
We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.